Atlas Trials

Evaluating Metabolic Mechanisms of Ertugliflozin in Diabetes & Heart Failure

Clinical trial NCT04071626 · TERMINATED

Trial details

NCT number
NCT04071626
Sponsor
University Hospitals Cleveland Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure, DiastolicDiabetes Mellitus, Type 2
Start date
2020-03-01
Primary completion
2023-01-11
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.